0001193125-26-099355
SEC filingCullinan Therapeutics, Inc. furnished a press release as Exhibit 99.1 under Items 2.02 and 9.01 of Form 8-K on March 10, 2026, pertaining to results of operations. The press release content is not provided in the filing excerpt.